ArticleCurrent oncology (Toronto, Ont.)2025

A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol

Robert W Holloway et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.